A comprehensive study spanning 17 years and involving over 730,000 people treated for high blood pressure has provided ...
The Central Drug Standards Control Organisation (CDSCO) has flagged more than 50 drugs for common conditions like high blood pressure and acid reflux as substandard. This includes batches from ...
In my previous article, I discussed how AI is rapidly transforming the drug discovery process, significantly accelerating timelines and reducing costs. However, while AI's potential in this domain ...
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...
The drug is sold for around US$100 per gram (£76) in Spain, and is often marketed as a high-end product. The legal response varies , with Spanish authorities working to curb its distribution .
Joseph Janes does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Research Fellow, National Drug and Alcohol Research Centre, UNSW Sydney Over the past five years, Rachel Sutherland has received research funding from the Australian Government Department of ...
It remains unclear why our patient did not develop the electrolyte abnormalities typical for furosemide-induced hypokalemia. Her concomitant hyponatremia cannot be explained by furosemide-intake ...
Three scientists involved in developing the blockbuster anti-obesity drugs that are currently changing the health-care landscape are among the winners of this year’s prestigious Lasker Awards.
FROM LOS ANGELES to London, weight-loss drugs such as Ozempic are reshaping culture as much as waistlines. Some Ozempic-takers have tiny appetites and dine at unusual hours to avoid spells of nausea.
The report, published on 16 September in The Lancet 1, found that between 1990 and 2021, more than one million people died from drug-resistant infections each year, and this could increase to ...
In this article, we discuss the global issue of drug shortages. We summarise our research where we developed a framework for quantifying the cost of a shortage, and through three case studies provide ...